Orthofix Medical Inc. Excess Tax Benefit from Share-based Compensation, Financing Activities
Orthofix Medical Inc. (OFIX) reported Excess Tax Benefit from Share-based Compensation, Financing Activities of $105.00 thousand for the 6-month period ending 2016-06-30, per its 10-Q filed 2016-08-01.
Discontinued › Notes › Compensation Related Costs
us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities · last filed 2016-08-01
- Orthofix Medical Inc. excess tax benefit from share-based compensation, financing activities for the quarter ending 2016-06-30 was -$117.00K.
- Orthofix Medical Inc. excess tax benefit from share-based compensation, financing activities for the quarter ending 2016-03-31 was $222.00K, a 289.47% increase year-over-year.
- Orthofix Medical Inc. excess tax benefit from share-based compensation, financing activities for the quarter ending 2015-12-31 was $83.00K, a 1975.00% increase year-over-year.
- Orthofix Medical Inc. excess tax benefit from share-based compensation, financing activities for the quarter ending 2015-09-30 was $249.00K, a 53.70% increase year-over-year.
- Orthofix Medical Inc. excess tax benefit from share-based compensation, financing activities for fiscal 2015 was $386.00K, a 87.38% increase from fiscal 2014.
- Orthofix Medical Inc. excess tax benefit from share-based compensation, financing activities for fiscal 2014 was $206.00K, a 151.22% increase from fiscal 2013.
- Orthofix Medical Inc. excess tax benefit from share-based compensation, financing activities for fiscal 2013 was $82.00K, a 91.96% decline from fiscal 2012.
- Orthofix Medical Inc. excess tax benefit from share-based compensation, financing activities for fiscal 2012 was $1.02M, a 41.28% decline from fiscal 2011.
| Period end | Excess Tax Benefit from Share-based Compensation, Financing Activities 3 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 3 month as first filed | Excess Tax Benefit from Share-based Compensation, Financing Activities 6 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 9 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 12 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2016-06-30 | -$117.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | $105.00K 10-Q · filed 2016-08-01 | $188.00K derived: sum of 3 quarters · filed 2016-08-01 | $437.00K derived: sum of 4 quarters · filed 2016-08-01 | ||
| 2016-03-31 | $222.00K 10-Q · filed 2016-04-28 | $305.00K derived: sum of 2 quarters · filed 2016-04-28 | $554.00K derived: sum of 3 quarters · filed 2016-04-28 | $551.00K derived: sum of 4 quarters · filed 2016-08-01 | ||
| 2015-12-31 | $83.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $332.00K derived: sum of 2 quarters · filed 2016-02-29 | $329.00K derived: sum of 3 quarters · filed 2016-08-01 | $386.00K 10-K · filed 2016-02-29 | ||
| 2015-09-30 | $249.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | $246.00K derived: sum of 2 quarters · filed 2016-08-01 | $303.00K 10-Q · filed 2015-11-03 | $307.00K derived: sum of 4 quarters · filed 2016-08-01 | ||
| 2015-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | $54.00K 10-Q · filed 2016-08-01 | $58.00K derived: sum of 3 quarters · filed 2016-08-01 | $220.00K derived: sum of 4 quarters · filed 2016-08-01 | ||
| 2015-03-31 | $57.00K 10-Q · filed 2016-04-28 | $61.00K derived: sum of 2 quarters · filed 2016-04-28 | $223.00K derived: sum of 3 quarters · filed 2016-04-28 | $234.00K derived: sum of 4 quarters · filed 2016-04-28 | ||
| 2014-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $166.00K derived: sum of 2 quarters · filed 2016-02-29 | $177.00K derived: sum of 3 quarters · filed 2016-02-29 | $206.00K 10-K · filed 2016-02-29 | ||
| 2014-09-30 | $162.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | $173.00K derived: sum of 2 quarters · filed 2015-11-03 | $202.00K 10-Q · filed 2015-11-03 | $202.00K derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-06-30 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $40.00K 10-Q · filed 2015-08-04 | $40.00K derived: sum of 3 quarters · filed 2016-02-29 | $40.00K derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-03-31 | $29.00K 10-Q · filed 2015-05-18 | $29.00K derived: sum of 2 quarters · filed 2016-02-29 | $29.00K derived: sum of 3 quarters · filed 2016-02-29 | $33.00K derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $0.00 derived: sum of 2 quarters · filed 2016-02-29 | $4.00K derived: sum of 3 quarters · filed 2016-02-29 | $82.00K 10-K · filed 2016-02-29 | ||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-31 | $4.00K derived: sum of 2 quarters · filed 2015-03-31 | $82.00K 10-Q · filed 2015-03-31 | -$1.22M derived: sum of 4 quarters · filed 2015-04-29 | ||
| 2013-06-30 | $4.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2015-03-31 | $82.00K 10-Q · filed 2015-03-31 | -$1.22M derived: sum of 3 quarters · filed 2015-04-29 | -$54.00K derived: sum of 4 quarters · filed 2015-04-29 | ||
| 2013-03-31 | $78.00K 10-Q/A · filed 2015-03-31 | -$1.22M derived: sum of 2 quarters · filed 2015-04-29 | -$58.00K derived: sum of 3 quarters · filed 2015-04-29 | $709.00K derived: sum of 4 quarters · filed 2015-04-29 | ||
| 2012-12-31 | -$1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-29 | -$136.00K derived: sum of 2 quarters · filed 2015-04-29 | $631.00K derived: sum of 3 quarters · filed 2015-04-29 | $1.02M 10-K · filed 2015-04-29 | ||
| 2012-09-30 | $1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-25 | $1.93M derived: sum of 2 quarters · filed 2014-03-25 | $2.32M 10-Q · filed 2014-03-25 | $2.48M derived: sum of 4 quarters · filed 2015-03-31 | ||
| 2012-06-30 | $767.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2014-03-24 | $1.16M 10-Q · filed 2014-03-24 | $1.32M derived: sum of 3 quarters · filed 2015-03-31 | $1.89M derived: sum of 4 quarters · filed 2015-03-31 | ||
| 2012-03-31 | $389.00K 10-Q/A · filed 2014-03-24 | $390.00K 10-Q · filed 2012-05-04 | $551.00K derived: sum of 2 quarters · filed 2015-03-31 | $1.12M derived: sum of 3 quarters · filed 2015-03-31 | $1.54M derived: sum of 4 quarters · filed 2015-03-31 | |
| 2011-12-31 | $162.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2015-03-31 | $733.00K derived: sum of 2 quarters · filed 2015-03-31 | $1.15M derived: sum of 3 quarters · filed 2015-03-31 | $1.74M 10-K/A · filed 2015-03-31 | ||
| 2011-09-30 | $571.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $990.00K derived: sum of 2 quarters · filed 2012-11-02 | $1.57M 10-Q · filed 2012-11-02 | $2.13M derived: sum of 4 quarters · filed 2014-03-24 | ||
| 2011-06-30 | $419.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-30 | $1.00M 10-Q · filed 2012-07-30 | $1.56M derived: sum of 3 quarters · filed 2014-03-24 | $1.63M derived: sum of 4 quarters · filed 2014-03-24 | ||
| 2011-03-31 | $585.00K 10-Q · filed 2012-05-04 | $1.14M derived: sum of 2 quarters · filed 2014-03-24 | $1.21M derived: sum of 3 quarters · filed 2014-03-24 | |||
| 2010-12-31 | $558.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-03-24 | $625.00K derived: sum of 2 quarters · filed 2014-03-24 | $2.42M 10-K/A · filed 2014-03-24 | $2.22M 10-K · filed 2012-02-29 | ||
| 2010-09-30 | $67.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $1.86M 10-Q · filed 2011-10-31 | ||||
| 2010-06-30 | $1.79M 10-Q · filed 2011-08-05 | |||||
| 2009-12-31 | $25.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |